Clinical Trial

Artificial Int: Neurogenic Bowel Education in Spinal Cord Injury Patients

Study acronym: ArtInt
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the effectiveness of patient education delivered through an artificial intelligence (AI)-based mobile application in the management of neurogenic bowel dysfunction in individuals with spinal cord injury. Within the scope of the study, it will be examined whether the mobile application reduces neurogenic bowel scores, contributes to maintaining stool scores within the normal range, and improves the quality of life of individuals. Accordingly, the AI-based education model to be developed is expected to facilitate the integration of bowel management practices into daily life, prevent complications, and enhance social participation. \-
Trial Details
NCT Number NCT07369349
Lead Sponsor Senem Duman
Conditions Spinal Cord Injury, Neurogenic Bowel Dysfunction
Enrollment 34 participants
Start Date 2026-02-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-27